Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FEIBA<sup>®</sup>: mode of action

1 Sept 2004

Abstract excerpt

FEIBA (factor eight inhibitor bypassing activity) has a history of more than 30 years of successful use in controlling bleeding in haemophilic patients who have developed inhibitory antibodies against factor (F)VIII or FIX. Recently it was shown that FEIBA contains the proenzymes of the prothrombin complex factors, prothrombin, FVII, FIX and FX, but only very small amounts of their activation products, with the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
Share to Hemophilia Treatment and Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15385040
DOI: 10.1111/j.1365-2516.2004.00934.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FEIBA<sup>®</sup>: mode of actionPMID 15385040Read ↗

Blood coagulation factor VIII: An overview.Semantic proximity Read ↗

In vitro evaluation of factor IX as novel treatment for factor XI deficiencySemantic proximity Read ↗

Novel molecules for the correction of factor Xa generation and phenotype in hemophilia.Semantic proximity Read ↗

Activation mechanisms of coagulation factor IX.Semantic proximity Read ↗

Structure-function relationships in thrombin-activatable fibrinolysis inhibitor.Semantic proximity Read ↗

Structure and function of factor XI.Semantic proximity Read ↗

FIXing factor VIII inhibitors.Semantic proximity Read ↗

Alternative therapies for the management of inhibitorsSemantic proximity Read ↗

Recent advances in developing specific therapies for haemophiliaSemantic proximity Read ↗

Thrombin activation of the factor XI dimer is a multistaged process for each subunit.Semantic proximity Read ↗

Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity.Semantic proximity Read ↗

New observations on factor XI deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.